Cargando…
Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory Ligand
PURPOSE: We assess the efficacy of two next-generation biologic therapies in treating experimental autoimmune uveitis. METHODS: Variable binding domains from shark immunoglobulin novel antigen receptors (VNARs) were fused with a mouse IgG2a constant domain (Fc) to generate VNAR-Fc molecules with bin...
Autores principales: | Pepple, Kathryn L., Wilson, Leslie, Van Gelder, Russell N., Kovaleva, Marina, Ubah, Obinna C., Steven, John, Barelle, Caroline J., Porter, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753974/ https://www.ncbi.nlm.nih.gov/pubmed/31588375 http://dx.doi.org/10.1167/tvst.8.5.11 |
Ejemplares similares
-
Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis
por: Kovaleva, Marina, et al.
Publicado: (2017) -
Novel, Anti-hTNF-α Variable New Antigen Receptor Formats with Enhanced Neutralizing Potency and Multifunctionality, Generated for Therapeutic Development
por: Ubah, Obinna C., et al.
Publicado: (2017) -
In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development
por: Steven, John, et al.
Publicado: (2017) -
Comparison of Aqueous and Vitreous Lymphocyte Populations From Two Rat Models of Experimental Uveitis
por: Pepple, Kathryn L., et al.
Publicado: (2018) -
An Anti-hTNF-α Variable New Antigen Receptor Format Demonstrates Superior in vivo Preclinical Efficacy to Humira® in a Transgenic Mouse Autoimmune Polyarthritis Disease Model
por: Ubah, Obinna C., et al.
Publicado: (2019)